Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Current Gene Therapy
|
July 12, 2002
Genetic approaches for antigen-selective cell therapy
L Alvarez-Vallina
European Journal of Immunology
|
October 1, 1996
Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors
L Alvarez-Vallina, R E Hawkins
Human Gene Therapy
|
March 27, 1999
Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies
L Alvarez-Vallina, S J Russell
Journal of Immunology (Baltimore, Md. : 1950)
|
April 29, 1998
Pharmacological control of antigen responsiveness in genetically modified T lymphocytes
L Alvarez-Vallina, S Agha-Mohammadi, R E Hawkins, et al.
Gene Therapy
|
February 12, 1998
Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues
S A-Mohammadi, L Alvarez-Vallina, L J Ashworth, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1993
Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T cell receptor)
L Alvarez-Vallina, A González, F Gambón, et al.
Cancer Gene Therapy
|
May 16, 2000
Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors
L Alvarez-Vallina, R Yañez, B Blanco, et al.
Cancer Immunology, Immunotherapy : CII
|
January 5, 2002
Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy
L Sanz, P Kristensen, S J Russell, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1995
Isolation of tumor-derived immunoglobulin-idiotype from peripheral blood mononuclear cells in a B-cell lymphoma patient with minimal disease
L Alvarez-Vallina, A Plaza, M Kreisler, et al.
Gene Therapy
|
January 12, 2017
Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity
K Mølgaard, M Compte, N Nuñez-Prado, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Current Gene Therapy
|
July 12, 2002
Genetic approaches for antigen-selective cell therapy
L Alvarez-Vallina
European Journal of Immunology
|
October 1, 1996
Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors
L Alvarez-Vallina, R E Hawkins
Human Gene Therapy
|
March 27, 1999
Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies
L Alvarez-Vallina, S J Russell
Journal of Immunology (Baltimore, Md. : 1950)
|
April 29, 1998
Pharmacological control of antigen responsiveness in genetically modified T lymphocytes
L Alvarez-Vallina, S Agha-Mohammadi, R E Hawkins, et al.
Gene Therapy
|
February 12, 1998
Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues
S A-Mohammadi, L Alvarez-Vallina, L J Ashworth, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1993
Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T cell receptor)
L Alvarez-Vallina, A González, F Gambón, et al.
Cancer Gene Therapy
|
May 16, 2000
Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors
L Alvarez-Vallina, R Yañez, B Blanco, et al.
Cancer Immunology, Immunotherapy : CII
|
January 5, 2002
Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy
L Sanz, P Kristensen, S J Russell, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1995
Isolation of tumor-derived immunoglobulin-idiotype from peripheral blood mononuclear cells in a B-cell lymphoma patient with minimal disease
L Alvarez-Vallina, A Plaza, M Kreisler, et al.
Gene Therapy
|
January 12, 2017
Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity
K Mølgaard, M Compte, N Nuñez-Prado, et al.
Page
of 2